(1R,2R)-N,N'-Bis(1-naphthalenylmethyl)-1,2-diphenyl-1,2-ethanediamine, 97%, 1g

4-Chloro-6-fluoro-2-(trifluoromethyl)quinazoline, 95.0%, 250mg

(2S,4S)-1-(TERT-BUTOXYCARBONYL)-4-(4-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)PIPERAZIN-1-YL)PYRROLIDINE-2-CARBOXYLIC ACID, 95%, 100mg

3-(4-CYCLOPROPYLPIPERAZIN-1-YL)ANILINE, 95.0%, 100mg

N-((2S,3R,4R,5S,6R)-2-(Benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide, 95.0%, 10g

Aluminum transport case

{1-[2-(Pyridin-4-yl)ethyl]piperidin-4-yl}methanamine, 5g

MESTRANOL, 98%, 1g

N-Bromoacetamide>97.0%(T)25g

2-Chloro-4-ethynylbenzoic acid, 97.0%, 100mg

Capsazepine, >99%, 5mg

4-Methyl-1-hexene>99.0%(GC)5mL

(S)-2-((tert-Butoxycarbonyl)amino)-3-(2,5-difluorophenyl)propanoic acid, 98%, 1g